Takeda Type 2 Diabetes Drug Outperforms Sanofi Drug – Study
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical reported a trial of its type 2 diabetes drug out-performed a generic version of a drug developed by Sanofi to lower blood sugar.